Clinical Trial Update: Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating exemestane after prior aromatase inhibitor therapy (anastrozole or letrozole) in postmenopausal women with hormone-responsive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Aromasin (exemestane)
• FEMARA (letrozole)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN